Depressing. I certainly don't trust Gold. I admit that I'm not very knowledgeable about CEGE's top management. I tend to place more confidence in the scientific studies published in various journals. The close and continuing relationship that John Hopkins has with GVAX and CEGE in different cancers is also somewhat encouraging. It is a shame to have to think of biotech investing as a potential game of Liar's Poker where the insiders always win. I have also noticed over the years that many biotech managers who had no role in the invention or development of a therapy or diagnostic, have never treated a patient or managed a successful business, think that they are entitled to a disproportionate share of compensation and congratulations for performing noble work. I suppose our male egos always have a way of distorting reality. Perhaps there should be a Hazard Ratio for biotech management. JMHO.
News 
Market Data 
Discover 
